Pause and Co Healthcare

Mind

ADHD & Menopause

Why ADHD symptoms often spike in perimenopause — and integrated management.

By Dr Nadira AwalBMS Specialist2 min readMedically reviewed 9 July 2026
Open leather planner with colour-coded sticky notes and a fountain pen

Falling oestrogen affects dopamine. Many women meet ADHD criteria for the first time in perimenopause; assessment and combined hormonal and stimulant care can transform daily life.

Perimenopause is one of the most common life stages for undiagnosed ADHD to become impossible to ignore. Oestrogen supports dopamine signalling in the brain's attention and reward networks — when it falls, the coping strategies women have built over decades (usually through sheer effort) stop keeping up. The result is not new ADHD; it is ADHD that was always there, finally unmasked. Recognising it changes lives.

Why perimenopause is the tipping point

  • Oestrogen boosts dopamine synthesis and receptor sensitivity — falling levels expose underlying dopaminergic weakness.
  • Sleep loss, hormonal fluctuation and life load simultaneously overload executive function.
  • Many women were missed as girls (inattentive presentation, high effort compensation, cultural expectations) and diagnosed only in midlife.
  • The same neurochemistry underlies premenstrual worsening of ADHD symptoms and postnatal ADHD flares — perimenopause is the biggest version.

Signs worth exploring

  • Escalating overwhelm, procrastination and time blindness.
  • Difficulty starting tasks, even ones you care about.
  • Emotional dysregulation, rejection sensitivity, mood crashes.
  • Sensory overwhelm — noise, light, clothing textures, background music.
  • Difficulty with transitions and 'boring but important' admin.
  • A lifelong pattern of high performance masking exhaustion — usually not brand new, though it may feel that way.

Care that works

  • HRT optimisation first — transdermal oestrogen often stabilises attention and mood significantly before any ADHD-specific treatment.
  • ADHD assessment via the NHS Right to Choose pathway or an accredited private service (Psychiatry UK, ADHD 360, Clinical Partners).
  • Stimulant medication (methylphenidate, lisdexamfetamine) or non-stimulant options (atomoxetine, guanfacine) where indicated — carefully monitored.
  • ADHD coaching, therapy for perfectionism and shame, and peer support.
  • Combined care — hormones plus ADHD treatment — outperforms either in isolation for most women.

Everyday supports

  • External scaffolding: timers (Pomodoro, visual clocks), lists, calendar prompts, alarms.
  • Body-doubling — working alongside someone else, in person or virtually.
  • Quiet, low-clutter workspaces; noise-cancelling headphones where useful.
  • Batch tasks by energy, not by category — hard cognitive work in your peak window.
  • Reduce decision load: capsule wardrobe, meal repetition, standing shopping lists.
  • Regular movement, protein-first eating and consistent sleep — all disproportionately helpful in ADHD.

What to look out for

  • Anxiety and depression are common companions of undiagnosed ADHD — treating only one often disappoints.
  • Alcohol and stimulant self-medication are common; both worsen sleep and mood.
  • Perimenstrual worsening is a strong clue in perimenopause — track it.

Where we fit in your care

  • We treat the menopause piece thoroughly and then work alongside your GP or ADHD service.
  • Where NHS ADHD waits are very long, Right to Choose or reputable private assessment can bring diagnosis within months.
  • We are careful not to reduce your whole midlife experience to hormones — some of what changes is neurodevelopmental, and needs to be named as such.

Key takeaway

If ADHD suddenly makes sense of your life in your 40s, you are not alone — and you are not too late. Menopause treatment and ADHD care together are often transformative.

How Dr Awal approaches this in clinic

Every consultation starts with your full story — symptoms, cycle, medical history, family history and what you've already tried. From there we look at whether hormonal treatment, non-hormonal options, lifestyle changes or a combination will give you the best result, and we tailor the plan to your age, risk factors and preferences.

  • A detailed 60 minute first appointment — no rushed 10-minute slots.
  • Evidence-based recommendations aligned with NICE NG23 and BMS guidance.
  • Body-identical HRT considered first-line where appropriate.
  • Shared-care letters sent to your NHS GP so treatment can continue affordably.
  • Follow-up at 3 months to fine-tune your regimen and address side effects.
  • Ongoing annual reviews so your plan evolves with you.

Common questions we hear about this

Do I need to be at a certain age to be seen?

No. We see women in early perimenopause (often late 30s and 40s), through post-menopause and beyond. Age alone doesn't decide whether treatment is right — symptoms, health history and goals do.

Will my GP continue the prescription?

In most cases yes. After your consultation we send a detailed shared-care letter with the diagnosis, treatment plan and rationale so your NHS GP can prescribe on the NHS. Not every practice accepts shared care — we'll discuss this in your appointment.

What if I've tried HRT before and it didn't suit me?

Very common — often the type, dose or route wasn't right rather than HRT itself. We review what you've tried, why it didn't work, and adjust accordingly. Many women who thought HRT wasn't for them do well on a different preparation.

How long will I need to stay on treatment?

There is no set upper time limit for HRT. Current BMS and NICE guidance supports continuing HRT for as long as the benefits outweigh the risks for you personally. We review this together every year so you stay in control of the decision.

Where do you see patients?

All consultations at Pause and Co Healthcare are conducted securely via video, allowing us to support patients anywhere in the UK. Prescriptions and shared care arrangements are managed in the same way, regardless of your location.

About the author

Dr Nadira Awal is a British Menopause Society Advanced Menopause Specialist with 15+ years' NHS and private experience. She holds the BMS Advanced Certificate in Menopause Care, sits on the BMS Programme Planning Group, and advises the UK Government Menopause Strategy Group. Read her full profile.

General information only — not a substitute for personalised medical advice. Always speak to your GP or a menopause specialist about your own situation.

Talk it through

Book a private consultation with Dr Awal

Get evidence-based, personalised advice on adhd & menopause and any related concerns.